The stock of Agilon Health Inc (AGL) has gone up by 36.94% for the week, with a -16.67% drop in the past month and a -48.69% drop in the past quarter. The volatility ratio for the week is 9.76%, and the volatility levels for the past 30 days are 9.49% for AGL. The simple moving average for the past 20 days is 0.02% for AGL’s stock, with a -56.70% simple moving average for the past 200 days.
Is It Worth Investing in Agilon Health Inc (NYSE: AGL) Right Now?
Company’s 36-month beta value is 0.51.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 14 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AGL is 303.27M, and currently, short sellers hold a 11.94% ratio of that floaft. The average trading volume of AGL on November 25, 2024 was 4.63M shares.
AGL) stock’s latest price update
The stock price of Agilon Health Inc (NYSE: AGL) has surged by 13.76 when compared to previous closing price of 1.89, but the company has seen a 36.94% gain in its stock price over the last five trading sessions. zacks.com reported 2024-11-19 that AGL, AFLYY and BATRK have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2024.
Analysts’ Opinion of AGL
Citigroup gave a rating of “Sell” to AGL, setting the target price at $2.50 in the report published on October 30th of the current year.
AGL Trading at -24.81% from the 50-Day Moving Average
After a stumble in the market that brought AGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.37% of loss for the given period.
Volatility was left at 9.49%, however, over the last 30 days, the volatility rate increased by 9.76%, as shares sank -21.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -35.52% lower at present.
During the last 5 trading sessions, AGL rose by +34.71%, which changed the moving average for the period of 200-days by -68.99% in comparison to the 20-day moving average, which settled at $2.1477. In addition, Agilon Health Inc saw -82.87% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AGL starting from Sell Steven, who purchase 20,000 shares at the price of $3.36 back on Sep 12 ’24. After this action, Sell Steven now owns 67,590 shares of Agilon Health Inc, valued at $67,188 using the latest closing price.
Schwaneke Jeffrey A., the Director of Agilon Health Inc, purchase 22,300 shares at $11.22 during a trade that took place back on Nov 29 ’23, which means that Schwaneke Jeffrey A. is holding 31,931 shares at $250,206 based on the most recent closing price.
Stock Fundamentals for AGL
Current profitability levels for the company are sitting at:
- -0.06 for the present operating margin
- -0.01 for the gross margin
The net margin for Agilon Health Inc stands at -0.06. The total capital return value is set at -0.51. Equity return is now at value -42.98, with -14.23 for asset returns.
Based on Agilon Health Inc (AGL), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -3.88. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is -52.31.
Currently, EBITDA for the company is -167.64 million with net debt to EBITDA at 0.35. When we switch over and look at the enterprise to sales, we see a ratio of 0.14. The receivables turnover for the company is 4.09for trailing twelve months and the total asset turnover is 2.67. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.29.
Conclusion
In a nutshell, Agilon Health Inc (AGL) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
